178 related articles for article (PubMed ID: 17323596)
1. Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
Echols MR; Yancy CW
Vasc Health Risk Manag; 2006; 2(4):423-31. PubMed ID: 17323596
[TBL] [Abstract][Full Text] [Related]
2. The African American Heart Failure Trial: a clinical trial update.
Taylor AL
Am J Cardiol; 2005 Oct; 96(7B):44-8. PubMed ID: 16226935
[TBL] [Abstract][Full Text] [Related]
3. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
Cheng JW
Clin Ther; 2006 May; 28(5):666-78. PubMed ID: 16861089
[TBL] [Abstract][Full Text] [Related]
4. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Hammermeister KE; Fairclough D; Emsermann CB; Hamman R; Ho M; Phibbs S; Plomondon M; Valuck R; West D; Steiner JF
Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
[TBL] [Abstract][Full Text] [Related]
6. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
Elkayam U; Bitar F
Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
[TBL] [Abstract][Full Text] [Related]
7. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
Thadani U; Jacob RG
Drugs Today (Barc); 2008 Dec; 44(12):925-37. PubMed ID: 19198701
[TBL] [Abstract][Full Text] [Related]
8. Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.
Ofili E; Anand I; Williams RA; Akinboboye O; Xu L; Puckrein G
Adv Ther; 2017 Aug; 34(8):1976-1988. PubMed ID: 28707284
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in heart failure therapeutics.
Ishizawar D; Yancy C
Heart Fail Clin; 2010 Jan; 6(1):65-74. PubMed ID: 19945062
[TBL] [Abstract][Full Text] [Related]
10. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN;
N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851
[TBL] [Abstract][Full Text] [Related]
11. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
[TBL] [Abstract][Full Text] [Related]
12. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Taylor AL; Ziesche S; Yancy CW; Carson P; Ferdinand K; Taylor M; Adams K; Olukotun AY; Ofili E; Tam SW; Sabolinski ML; Worcel M; Cohn JN;
Circulation; 2007 Apr; 115(13):1747-53. PubMed ID: 17372175
[TBL] [Abstract][Full Text] [Related]
13. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
Ziaeian B; Fonarow GC; Heidenreich PA
JACC Heart Fail; 2017 Sep; 5(9):632-639. PubMed ID: 28711446
[TBL] [Abstract][Full Text] [Related]
14. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
Ferdinand KC; Elkayam U; Mancini D; Ofili E; Piña I; Anand I; Feldman AM; McNamara D; Leggett C
Am J Cardiol; 2014 Jul; 114(1):151-9. PubMed ID: 24846808
[TBL] [Abstract][Full Text] [Related]
15. A-HeFT: old dog, new endothelial tricks.
Cohn JN
Tex Heart Inst J; 2005; 32(3):366-8. PubMed ID: 16392220
[TBL] [Abstract][Full Text] [Related]
16. The use of race and ethnicity in medicine: lessons from the African-American Heart Failure Trial.
Cohn JN
J Law Med Ethics; 2006; 34(3):552-4, 480. PubMed ID: 17144178
[TBL] [Abstract][Full Text] [Related]
17. African American heart failure trial: role of endothelial dysfunction and heart failure in African Americans.
Ferdinand KC
Am J Cardiol; 2007 Mar; 99(6B):3D-6D. PubMed ID: 17378993
[TBL] [Abstract][Full Text] [Related]
18. Food & Drug Administration panel approves heart failure medication aimed at African-Americans.
Pharmacogenomics; 2005 Jul; 6(5):455. PubMed ID: 16705760
[No Abstract] [Full Text] [Related]
19. BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
Carmody MS; Anderson JR
Cardiol Rev; 2007; 15(1):46-53. PubMed ID: 17172884
[TBL] [Abstract][Full Text] [Related]
20. G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.
McNamara DM; Taylor AL; Tam SW; Worcel M; Yancy CW; Hanley-Yanez K; Cohn JN; Feldman AM
JACC Heart Fail; 2014 Dec; 2(6):551-7. PubMed ID: 25306451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]